New Ozempic danger: FDA updates label to warn users of intestinal blockage
The U.S. Food and Drug Administration has updated the Ozempic label to acknowledge complaints of blocked intestines in some people who have taken the medication. The semaglutide drug is designed for people with Type 2 diabetes but has become widely used as a weight-loss remedy. Ozempic works by mimicking a natural hormone, GLP-1, which slows down the passage … Read more